David Shank

David Shank has extensive experience in manufacturing operations within the biotechnology and pharmaceutical industries. Currently serving as Vice President of Manufacturing at Lyell Immunopharma since August 2019, David has held various leadership roles throughout their career, including Senior Director of Manufacturing Operations at Juno Therapeutics and Director of the Cell Processing Facility at the Fred Hutchinson Cancer Research Center. David's background also includes significant positions at CMC ICOS Biologics, CellPro, Inc., and Scios, Inc., where responsibilities spanned manufacturing and lab services.